Literature DB >> 22482770

Incidence of concomitant hyperparathyroidism in patients with thyroid disease requiring surgery.

Sara E Murray1, Rebecca S Sippel, Herbert Chen.   

Abstract

BACKGROUND: Thyroid disease and hyperparathyroidism (HPT) are among the most common endocrine disorders, however, their association has not been well established. The aim of the present study was to determine the incidence of concomitant HPT in patients with thyroid disease requiring surgery, because a single definitive surgery should ideally be performed.
METHODS: We retrospectively reviewed a prospectively maintained database of patients who underwent thyroidectomy at a single institution. Data collected included the patients' initial indication for surgery, preoperative workup, and operative findings.
RESULTS: Of the 1,049 patients who underwent thyroidectomy, 56 (5%) had concomitant HPT and underwent simultaneous parathyroidectomy. Of these 56 patients, 36 initially presented with thyroid disease and 20 with HPT. The mean age was 59 ± 2 years, and 79% were women. The mean preoperative calcium and parathyroid hormone levels were elevated at 10.4 ± 0.1 mg/dL and 87 ± 7 pg/mL, respectively. Most of these patients had primary HPT (n = 54, 96%). Of the 36 patients presenting initially with thyroid disease, 26 had an elevated calcium or parathyroid hormone value and were preoperatively diagnosed with HPT. The remaining 10 patients had normal laboratory findings; however, a pathologically enlarged parathyroid gland was found at thyroidectomy. The overall cure rate for HPT within our series was 96%.
CONCLUSION: The incidence of concomitant HPT in patients with thyroid disease requiring surgery is significant at 5%. Recognition of concurrent disease is important, because it allows for a single definitive surgery to treat both pathologies.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22482770      PMCID: PMC3408846          DOI: 10.1016/j.jss.2012.03.008

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  22 in total

1.  Incidental preclinical hyperparathyroidism identified during thyroid operations.

Authors:  A D Katz; L B Kong
Journal:  Am Surg       Date:  1992-12       Impact factor: 0.688

2.  Surgery improves quality of life in patients with "mild" hyperparathyroidism.

Authors:  Joel T Adler; Rebecca S Sippel; Sarah Schaefer; Herbert Chen
Journal:  Am J Surg       Date:  2009-03       Impact factor: 2.565

3.  Coexistence of primary hyperparathyroidism and thyroid disease.

Authors:  M Regal; C Páramo; R Luna Cano; L F Pérez Méndez; J M Sierra; I Rodríguez; R V García-Mayor
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

4.  Significant clinical differences in primary hyperparathyroidism between patients with and those without concomitant thyroid disease.

Authors:  Toshihiro Masatsugu; Hiroyuki Yamashita; Shiro Noguchi; Ryuichi Nishii; Shin Watanabe; Shinya Uchino; Syoji Kuroki; Masao Tanaka
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

5.  Coexistent thyroid pathologies and high rate of papillary cancer in patients with primary hyperparathyroidism: controversies about minimal invasive parathyroid surgery.

Authors:  M Kösem; E Algün; C Kotan; M Harman; M Oztürk
Journal:  Acta Chir Belg       Date:  2004-10       Impact factor: 1.090

Review 6.  Preoperative localization and minimally invasive management of primary hyperparathyroidism concomitant with thyroid disease.

Authors:  Yi-xiong Zheng; Shao-ming Xu; Ping Wang; Li Chen
Journal:  J Zhejiang Univ Sci B       Date:  2007-09       Impact factor: 3.066

7.  The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.

Authors:  Mishaela R Rubin; John P Bilezikian; Donald J McMahon; Thomas Jacobs; Elizabeth Shane; Ethel Siris; Julia Udesky; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

Review 8.  Association of hyperparathyroidism with nonmedullary thyroid carcinoma: review of 31 cases.

Authors:  J N Attie; R Vardhan
Journal:  Head Neck       Date:  1993 Jan-Feb       Impact factor: 3.147

9.  Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial.

Authors:  Elena Ambrogini; Filomena Cetani; Luisella Cianferotti; Edda Vignali; Chiara Banti; Giuseppe Viccica; Annalisa Oppo; Paolo Miccoli; Piero Berti; John P Bilezikian; Aldo Pinchera; Claudio Marcocci
Journal:  J Clin Endocrinol Metab       Date:  2007-05-29       Impact factor: 5.958

10.  Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a risk-benefit analysis.

Authors:  Kelly R Egan; Joel T Adler; Jordan E Olson; Herbert Chen
Journal:  J Surg Res       Date:  2007-06-15       Impact factor: 2.192

View more
  9 in total

1.  The coexistence of primary hyperparathyroidism and thyroid nodules: should the preoperative work-up of the parathyroid and the thyroid diseases be specifically adjusted?

Authors:  G Scerrino; M Attard; C Lo Piccolo; A Attard; G I Melfa; C Raspanti; M Zarcone; S Bonventre; S Mazzola; G Gulotta
Journal:  G Chir       Date:  2016 May-Jun

2.  Concomitant thyroid disease and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy.

Authors:  Marie-Christine Wright; Kelly Jensen; Hossam Mohamed; Carolyn Drake; Khuzema Mohsin; Dominique Monlezun; Nuha Alsaleh; Emad Kandil
Journal:  Gland Surg       Date:  2017-08

3.  Surgical treatment of concomitant thyroid and parathyroid disorders: analysis of 4882 cases.

Authors:  Milan D Jovanovic; Vladan R Zivaljevic; Aleksandar D Diklic; Branislav R Rovcanin; Goran V Zoric; Ivan R Paunovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-12       Impact factor: 2.503

4.  Preventing postoperative hypocalcemia in patients with Graves disease: a prospective study.

Authors:  Sarah C Oltmann; Andrew V Brekke; David F Schneider; Sarah C Schaefer; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2014-09-12       Impact factor: 5.344

5.  Does Primary Hyperparathyroidism Have an Association with Thyroid Papillary Cancer? A Retrospective Cohort Study.

Authors:  Kenan Çetin; Hasan E Sıkar; Şule Temizkan; Cem B Ofluoğlu; Ayşenur Özderya; Kadriye Aydın; Aylin E Gül; Hasan F Küçük
Journal:  World J Surg       Date:  2019-05       Impact factor: 3.352

6.  An intact parathyroid hormone-based protocol for the prevention and treatment of symptomatic hypocalcemia after thyroidectomy.

Authors:  Yvette Carter; Herbert Chen; Rebecca S Sippel
Journal:  J Surg Res       Date:  2013-10-08       Impact factor: 2.192

7.  Higher prevalence of Concomitant Hyperparathyroidism in African American Patients Undergoing Thyroid Surgery.

Authors:  Gianina C Hernández-Márquez; Jessica Fazendin; Ruth Obiarinze; Jonathan Dismukes; Brenessa Lindeman; Herbert Chen
Journal:  J Surg Res       Date:  2021-04-02       Impact factor: 2.417

8.  Is primary hyperparathyroidism a risk factor for papillary thyroid cancer? An exemplar study and literature review.

Authors:  Udi Cinamon; Dalia Levy; Tal Marom
Journal:  Int Arch Otorhinolaryngol       Date:  2014-12-08

9.  Long-term therapeutic outcomes of papillary thyroid carcinoma with concomitant hyperparathyroidism: A single center case-control study.

Authors:  Chih-Yiu Tsai; Szu-Tah Chen; Chuen Hsueh; Yann-Sheng Lin; Jen-Der Lin
Journal:  Biomed J       Date:  2020-02-27       Impact factor: 4.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.